Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Interference01:23

RNA Interference

26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Types of RNA01:20

Types of RNA

5.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
5.8K
RNA Editing02:23

RNA Editing

9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Experimental RNAi02:15

Experimental RNAi

6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Riboswitches01:56

Riboswitches

8.1K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iterative Bump-and-Hole Engineering Creates a Bioorthogonal Reporter for <i>N</i>-Acetylglucosaminyltransferase I.

Journal of the American Chemical Society·2026
Same author

Aβ Aggregates Bind the U1 Spliceosomal Ribonucleoprotein in Alzheimer Disease Brain.

bioRxiv : the preprint server for biology·2026
Same author

TMPRSS2-mediated coronavirus spike activation and inhibition.

Nature structural & molecular biology·2026
Same author

GlycoDiveR: a modular R framework to analyze and visualize highly dimensional glycoproteomics data.

bioRxiv : the preprint server for biology·2026
Same author

Understanding <i>m</i>/<i>z</i> Range Settings for MS/MS Scans: A Case Study with Intact Glycopeptides.

Journal of the American Society for Mass Spectrometry·2026
Same author

GlycoRNA complexed with heparan sulfate regulates VEGF-A signalling.

Nature·2026
Same journal

Cell Surface Glycans: From Recognition Technologies and Functional Editing to Medical Applications.

Glycobiology·2026
Same journal

Aberrant O-glycosylation genes and miR-21-5p targets define a molecular signature of tumor aggressiveness in triple-negative breast cancer.

Glycobiology·2026
Same journal

Cancer-Associated Alterations In O-GalNAc Glycosylation.

Glycobiology·2026
Same journal

Glyco you should know.

Glycobiology·2026
Same journal

Biosynthesis of human milk oligosaccharides (HMOs) in glycoengineered human cells.

Glycobiology·2026
Same journal

Glyco you should know.

Glycobiology·2026
See all related articles

Related Experiment Video

Updated: Jul 14, 2025

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads
08:48

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads

Published on: December 9, 2020

2.2K

Galectin-3 does not interact with RNA directly.

Egan L Peltan1,2, Nicholas M Riley2,3, Ryan A Flynn4,5

  • 1Department of Chemical and Systems Biology, Stanford University School of Medicine, 269 Campus Drive CCSR 4145 Stanford, CA 94305, United States.

Glycobiology
|October 10, 2023
PubMed
Summary
This summary is machine-generated.

Galectin-3 is not a direct RNA-binding protein. Studies show antibodies isolating RNA-protein crosslinks were due to hnRNPA2B1, not galectin-3 itself.

Keywords:
GALECTINSGalectin-3RNA-binding proteinshnRNPA2B1

More Related Videos

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
11:11

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

8.1K
Identification of RNAs Engaged in Direct RNA-RNA Interaction with a Long Non-Coding RNA
07:24

Identification of RNAs Engaged in Direct RNA-RNA Interaction with a Long Non-Coding RNA

Published on: July 9, 2021

2.5K

Related Experiment Videos

Last Updated: Jul 14, 2025

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads
08:48

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads

Published on: December 9, 2020

2.2K
Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
11:11

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

8.1K
Identification of RNAs Engaged in Direct RNA-RNA Interaction with a Long Non-Coding RNA
07:24

Identification of RNAs Engaged in Direct RNA-RNA Interaction with a Long Non-Coding RNA

Published on: July 9, 2021

2.5K

Area of Science:

  • Molecular Biology
  • Glycobiology
  • RNA Biology

Background:

  • Galectin-3, a known glycan-binding protein, was proposed as a dual-function protein with RNA-binding capabilities.
  • This putative role suggested a link between glycobiology and RNA biology, particularly in pre-mRNA splicing.
  • Previous evidence relied on affinity reagents lacking genetic validation, leaving direct RNA interaction unconfirmed.

Purpose of the Study:

  • To investigate the direct RNA-binding capacity of galectin-3.
  • To determine if galectin-3 interacts with RNA in cellular processes like pre-mRNA maturation.
  • To clarify the molecular basis of previously observed RNA-protein associations involving galectin-3.

Main Methods:

  • Utilized antibodies against endogenous human galectin-3 for immunoprecipitation (IP) of RNA-protein crosslinks.
  • Performed proteomic analysis of IP isolates.
  • Generated LGALS3 knock-out and HNRNPA2B1 knock-out cell lines.
  • Introduced an epitope tag to the endogenous C-terminal locus of LGALS3 for targeted isolation.

Main Results:

  • Anti-galectin-3 antibodies isolated RNA-protein crosslinks, but this was independent of LGALS3 gene expression.
  • Proteomic analysis revealed hnRNPA2B1, an RNA-binding protein, was highly abundant in isolates.
  • Genetic ablation of HNRNPA2B1, but not LGALS3, abolished RNA-protein crosslink isolation.
  • Isolation of epitope-tagged galectin-3 did not yield RNA-protein crosslinks.

Conclusions:

  • Galectin-3 does not appear to directly interact with RNA.
  • Observed RNA associations were likely due to cross-reactivity or indirect interactions involving hnRNPA2B1.
  • The identification of galectin-3 as an RNA-binding protein may be a misinterpretation, particularly in HeLa cells.
  • Recommends using gene deletions and endogenous epitope tags for precise evaluation of protein-RNA interactions.